4.8 Article

The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity

Journal

CELL REPORTS
Volume 20, Issue 7, Pages 1692-1704

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2017.07.055

Keywords

-

Categories

Funding

  1. USNIH [R01GM115366, R01CA160417, R01CA181450]
  2. Natural Science Foundation of Guangdong Province [2016A030308011]
  3. American Cancer Society [RSG-16-014-01-CDD]
  4. National Natural Science Foundation of China [31671435, 81400132, 8177100253]
  5. National Funds of Developing Local Colleges and Universities Grant [B16056001]
  6. Frontier and Key Technology Innovation Special Grant from the Department of Science and Technology of Guangdong Province [2016B030229008]
  7. Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme
  8. University of Pittsburgh Cancer Institute [P30CA047904]
  9. Ligue contre le Cancer (equipe labelisee)
  10. Agence National de la Recherche (ANR) Projets blancs
  11. ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases
  12. Association pour la recherche sur le cancer (ARC)
  13. Canceropole Ile-de-France
  14. Institut National du Cancer (INCa)
  15. Institut Universitaire de France
  16. Fondation pour la Recherche Medicale (FRM)
  17. European Commission (ArtForce)
  18. European Research Council (ERC)
  19. LeDucq Foundation
  20. LabEx Immuno-Oncology
  21. RHU Torino Lumiere
  22. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  23. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  24. Paris Alliance of Cancer Research Institutes (PACRI)

Ask authors/readers for more resources

Ferroptosis is a form of regulated cell death that may facilitate the selective elimination of tumor cells. The tumor suppressor p53 (TP53) has been demonstrated to promote ferroptosis via a transcriptiondependent mechanism. Here, we show that TP53 limits erastin-induced ferroptosis by blocking dipeptidyl-peptidase-4 (DPP4) activity in a transcription-independent manner. Loss of TP53 prevents nuclear accumulation of DPP4 and thus facilitates plasma-membrane-associated DPP4-dependent lipid peroxidation, which finally results in ferroptosis. These findings reveal a direct molecular link between TP53 and DPP4 in the control of lipid metabolism and may provide a precision medicine strategy for the treatment of colorectal cancer by induction of ferroptosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available